Faahfaahin Deg Deg ah
Qalabkani wuxuu qaadanayaa kaliya 15-20 daqiiqo si loo helo natiijooyinka baaritaanka
Hawlgallada qalabkani waa ka fudud yihiin oo dhaqso badan, muunadduna way fududahay in la kaydiyo
Qalabkani waxa uu dhamaystiri karaa tijaabada iyada oo aan la helin reagents dheeraad ah
Qalabkani waxa uu leeyahay sifooyinka dareenka sare iyo saxnaanta sare
Baakadaha & Bixinta
| Faahfaahinta baakadaha: Xidhmada dhoofinta caadiga ah Faahfaahinta keenista: 7-10 maalmood gudahooda ka dib helitaanka lacag bixinta |
Tilmaamaha
Qalabka antigen ee jaban ee COVID-19 AMDNA08
Novel Coronavirus (COVID-19) Qalabka Ogaanshaha Antigen-ka AMDNA08 (Latex Immunochromatography)
Qalabka antigen ee jaban ee COVID-19 AMDNA08
Tan iyo markii uu dillaacay novel coronavirus (COVID-19) dhammaadkii 2019, dadka cudurka qaba ayaa ku faafay adduunka oo dhan.Ururka Caafimaadka Adduunka (WHO) ayaa ku dhawaaqay in cudurka uu keeno fayraskan si rasmi ah loogu magacaabay COVID-19, iyo Guddiga Caalamiga ah ee Kala-saarista Fayrasyada (ICTV) ayaa si rasmi ah ugu dhawaaqay coronavirus-ka cusub.Waxaa loo magacaabay SARS-CoV-2, sidoo kale loo yaqaan 2019-nCoV, SARS-CoV-2 waxaa iska leh genus β-coronavirus.
Soo-dhoweeyaha shaqada ugu weyn ee SARS-CoV-2 waa ACE2, iyo tan ka sii muhiimsan, SARS-CoV-2 Awoodda isku-darka ACE2 aad ayey uga sareysaa fayraska SARS, taasoo ka dhigaysa SARS-CoV-2 inay hesho awood gudbin oo xooggan waa tijaabo adag oo loogu talagalay ka hortagga iyo xakamaynta faafidda iyo daawaynta caafimaadka.
Habka Qiimaha jaban ee COVID-19 Qalabka Antigen-ka AMDNA08 wuxuu leeyahay faa'iidooyin muuqda xagga dareenka waana hab lagu ogaado cudurka 'coronaviruses' cusub.Marka la eego xaaladda hadda jirta ee faafitaanka sare iyo tirada badan ee dadka cudurka qaba, ogaanshaha saxda ah iyo degdegga ah waxay caawin doontaa ka hortagga iyo xakameynta faafitaanka iyo daawaynta.
Qalabka cusub ee coronavirus (COVID-19) xirmada ogaanshaha antigen AMDNA08 waa kaadhka tijaabada in vitro ee go'aaminta coronavirus novel ee sanbabada sanbabada (NP).Qalabkani waxa uu ku gaadhaa ujeedada ogaanshaha isagoo isku daraya novel coronavirus (COVID-19) antigen iyo novel coronavirus (COVID-19) antibody si loo sameeyo iskudhaf falcelin ah oo loogu talagalay samaynta midabka.Alaabtani waxay si degdeg ah oo sax ah u baari kartaa novel coronavirus (COVID-19).
Qalabka ogaanshaha Antigen-ka ee COVID-19 AMDNA08 Faa'iidada
1. Qalabkani waxa uu qaataa 15-20 daqiiqo oo kaliya si loo helo natiijada baaritaanka.
2. Hawlgallada qalabkani waa ka fudud yihiin oo dhaqso badan, muunadduna way fududahay in la kaydiyo.
3. Xidhmadani waxa ay dhamaystiri kartaa tijaabada iyada oo aan la helin reagents dheeraad ah.
4. Qalabkani waxa uu leeyahay sifooyinka dareenka sare iyo saxnaanta sare.
5. Waxay ka kooban tahay 7-14 maalmood ee daaqada ee ogaanshaha unugyada difaaca jirka taaj cusub
Qalabka ogaanshaha Antigen-ka ee COVID-19 AMDNA08 Waxqabadka alaabta
1. Heerka isku dhaca togan: Tijaabi 5 novel coronavirus (COVID-19) recombinant antigen tixraac agabka tixraaca (P1~P5), natiijaduna waa inay dhamaantood noqdaan kuwo togan.
2. Heerka isku-dhac xun: 5 koobi oo ah novel coronavirus (COVID-19) recombinant antigen tixraac sheyga (N1 ~ N5) ayaa la tijaabiyay, natiijaduna waa inay dhamaantood noqdaan kuwo taban.
3. Xadka ogaanshaha ugu yar: 3 koobi oo ah novel coronavirus (COVID-19) recombinant antigen tixraac walxaha (L1~L3) waa in la tijaabiyaa, L1 waa in ay ahaadaan taban, L2 iyo L3 waa in ay noqdaan kuwo togan.
4. Ku celcelinta: Ku celi tijaabada novel coronavirus (COVID-19) tixraaca antigen recombinant (R) 10 jeer, natiijaduna waa inay noqotaa mid togan.
